| Literature DB >> 23686385 |
Mary J Harner1, Andreas O Frank, Stephen W Fesik.
Abstract
Nuclear magnetic resonance (NMR) spectroscopy has evolved into a powerful tool for fragment-based drug discovery over the last two decades. While NMR has been traditionally used to elucidate the three-dimensional structures and dynamics of biomacromolecules and their interactions, it can also be a very valuable tool for the reliable identification of small molecules that bind to proteins and for hit-to-lead optimization. Here, we describe the use of NMR spectroscopy as a method for fragment-based drug discovery and how to most effectively utilize this approach for discovering novel therapeutics based on our experience.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23686385 PMCID: PMC3699969 DOI: 10.1007/s10858-013-9740-z
Source DB: PubMed Journal: J Biomol NMR ISSN: 0925-2738 Impact factor: 2.835